$4.80
-0.01[-0.21%]
Last update: 7:49PM Get Real Time Here
Aurinia Pharmaceuticals
(NASDAQ:AUPH)Latest News for Aurinia Pharmaceuticals Stock (NASDAQ:AUPH)
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH)
Categories: All
Friday, March 01, 2024
Thursday, February 29, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
Friday, February 16, 2024
Thursday, February 15, 2024
- Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 15, 2024, 1:20PM
- Aurinia Pharmaceuticals shares are trading lower after the company reported mixed Q4 financial results and said it did not find a buyer after conducting a strategic business review.Benzinga Newsdesk - Feb 15, 2024, 10:23AM
- Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock BuybackVandana Singh - Feb 15, 2024, 9:51AM
- Aurinia Pharmaceuticals Initiates Share Repurchase Program Of Up To $150MBenzinga Newsdesk - Feb 15, 2024, 6:09AM
- Aurinia Pharmaceuticals Reaffirms 2024 Revenue Guidance Of $200M-$220M vs $217.87M Est.Benzinga Newsdesk - Feb 15, 2024, 6:04AM
- Aurinia Pharmaceuticals Q4 2023 GAAP EPS $(0.19) Misses $(0.16) Estimate, Sales $45.10M Beat $44.33M EstimateBenzinga Newsdesk - Feb 15, 2024, 6:00AM
- Earnings Scheduled For February 15, 2024Benzinga Insights - Feb 15, 2024, 5:17AM
- Reuters Reported Aurinia Finds No Buyer, To Announce $150M Share BuybackCharles Gross - Feb 15, 2024, 5:11AM
Wednesday, February 14, 2024
Friday, January 05, 2024
- What's Going On With Aurinia Pharmaceuticals Stock?Erica Kollmann - Jan 5, 2024, 10:56AM
- Aurinia Pharmaceuticals Reports Preliminary Unaudited Total Net Revenue For Q4 Of $45M Vs. Estimate Of $44.2M And And Full Year 2023 Preliminary Revenue Of $176M Vs. $174.71M EstimateBenzinga Newsdesk - Jan 5, 2024, 6:26AM
Wednesday, December 20, 2023
Tuesday, November 21, 2023
Monday, November 20, 2023
Monday, November 13, 2023
Tuesday, November 07, 2023
Thursday, November 02, 2023
- Aurinia Presents Breadth Of Data At ASN 2023 Demonstrating Clinical Importance Of LUPKYNIS For Managing Lupus NephritisBenzinga Newsdesk - Nov 2, 2023, 6:02PM
- Aurinia Pharmaceuticals Had Cash, Cash Equivalents And Restricted Cash And Investments Of $338.5M As Of September 30, 2023Benzinga Newsdesk - Nov 2, 2023, 6:19AM
- Aurinia Pharmaceuticals Narrows FY23 Lupkynis (Voclosporin) Sales Guidance Range To $155M-$160M Compared To Prior Range Of $150M-$160MBenzinga Newsdesk - Nov 2, 2023, 6:19AM
- Aurinia Pharmaceuticals Q3 EPS $(0.09) Beats $(0.17) Estimate, Sales $54.52M May Not Be Comparable To $38.50M EstimateBenzinga Newsdesk - Nov 2, 2023, 6:03AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Monday, October 30, 2023
Friday, September 22, 2023
Thursday, September 21, 2023
Monday, August 21, 2023
Monday, August 07, 2023
Thursday, August 03, 2023
- Earnings Scheduled For August 3, 2023Benzinga Insights - Aug 3, 2023, 6:59AM
- Aurinia Pharmaceuticals Increases 2023 Revenue Guidance Range From $135M-$155M To $150M-$160M From Net Product Sales Of LUPKYNIS (voclosporin)Benzinga Newsdesk - Aug 3, 2023, 6:16AM
- Aurinia Pharmaceuticals Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $41.49M Beat $36.37M EstimateBenzinga Newsdesk - Aug 3, 2023, 6:02AM
Wednesday, July 19, 2023
Thursday, July 06, 2023
Friday, June 30, 2023
- Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jun 30, 2023, 12:34PM
- Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On FridayLisa Levin - Jun 30, 2023, 10:27AM
- Why Are Aurinia Pharmaceuticals Shares Trading Higher TodayVandana Singh - Jun 30, 2023, 8:42AM
- Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 30, 2023, 8:12AM
- Aurinia Pharma shares are trading higher after the board announces exploration of strategic alternatives to maximize shareholder value.Benzinga Newsdesk - Jun 30, 2023, 4:35AM
Thursday, June 29, 2023
- Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks TodayBenzinga Newsbot - Jun 29, 2023, 9:01PM
- Aurinia Pharmaceuticals To Consider Range Of Options For Company Including, But Not Limited To, A Potential Sale, Merger Or Other OptionsHappy Mohamed - Jun 29, 2023, 4:07PM
- Aurinia Board Of Directors Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value; Has Accepted Recent Director Resignations And Has Initiated A Search For New DirectorsHappy Mohamed - Jun 29, 2023, 4:07PM
- Aurinia Pharmaceuticals Shares Halted, News PendingHappy Mohamed - Jun 29, 2023, 4:01PM